These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 8439978)

  • 21. Monoclonal antibody-drug conjugate therapy for the patients with colorectal cancer.
    Takahashi T; Yamaguchi T; Kitamura K; Noguchi A; Honda M
    Tohoku J Exp Med; 1992 Oct; 168(2):371-4. PubMed ID: 1306322
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Decreased renal accumulation of biotinylated chimeric monoclonal antibody-neocarzinostatin conjugate after administration of avidin.
    Otsuji E; Yamaguchi T; Yamamoto K; Matsumura H; Tsuruta H; Yata Y; Nishi H; Okamoto K; Kitamura K; Takahashi T
    Jpn J Cancer Res; 1997 Feb; 88(2):205-12. PubMed ID: 9119750
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Missile therapy of colorectal and pancreatic cancers--clinical trial of monoclonal antibody, A7-NCS, in 73 patients with colorectal and pancreatic cancers].
    Takahashi T; Yamaguchi T; Kitamura K; Noguchi A; Honda M; Otsuji E
    Gan To Kagaku Ryoho; 1990 Jun; 17(6):1111-9. PubMed ID: 2140933
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Follow-up study of patients treated with monoclonal antibody-drug conjugate: report of 77 cases with colorectal cancer.
    Takahashi T; Yamaguchi T; Kitamura K; Noguchi A; Honda M; Otsuji E
    Jpn J Cancer Res; 1993 Sep; 84(9):976-81. PubMed ID: 8407566
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [A new application of immunoconjugate to reduce the local recurrence of colorectal cancer].
    Kitamura K; Yamaguchi T; Taniguchi K; Katoh M; Kotani T; Yamaoka N; Otsuji E; Noguchi A; Takahashi T
    Gan To Kagaku Ryoho; 1993 Dec; 20(15):2357-60. PubMed ID: 8259851
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Immunoresponses and efficacy after arterial infusion of immunoconjugate A7-NCS in patients with colon cancer].
    Honda M; Yamaguchi T; Ohtsuji E; Noguchi A; Chimori Y; Doi M; Kamiguchi M; Noguchi A; Kitamura K; Yokota T
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1811-4. PubMed ID: 2143891
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Antitumor effect of neocarzinostatin conjugated to human/mouse chimeric Fab fragments of the monoclonal antibody A7 on human pancreatic carcinoma.
    Otsuji E; Yamaguchi T; Yata Y; Nishi H; Okamoto K; Taniguchi K; Kato M; Kotani T; Yamaoka N; Kitamura K
    J Surg Oncol; 1994 Dec; 57(4):230-4. PubMed ID: 7990477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antitumor resistance induced by zinostatin stimalamer (ZSS), a polymer-conjugated neocarzinostatin (NCS) derivative. I. Meth A tumor eradication and tumor-neutralizing activity in mice pretreated with ZSS or NCS.
    Masuda E; Maeda H
    Cancer Immunol Immunother; 1995 May; 40(5):329-38. PubMed ID: 7600566
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Anti-tumor activity of T-2 toxin-conjugated A7 monoclonal antibody (T-2-A7 MoAb) against human colon carcinoma.
    Kojima S; Nakamura N; Ueno Y; Yamaguchi T; Takahashi T
    Nat Toxins; 1993; 1(4):209-15. PubMed ID: 8167936
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Decreased production of anti-mouse antibody after administration of human/mouse chimeric monoclonal antibody-neocarzinostatin conjugate to human.
    Yata Y; Otsuji E; Okamoto K; Tsuruta H; Kobayashi S; Toma A; Yamagishi H
    Hepatogastroenterology; 2003; 50(49):80-4. PubMed ID: 12629996
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Changes in expression of the antigen recognized by monoclonal antibody A7 in human pancreatic carcinoma cells following exposure to anticancer agents.
    Yamaguchi T; Yamaoka N; Kitamura K; Otsuji E; Okamoto K; Tsuruta H; Yata Y; Takahashi T
    Cancer Lett; 1998 Apr; 126(2):165-72. PubMed ID: 9585062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Targeting chemotherapy of colorectal cancer by monoclonal antibody conjugated antitumor drug].
    Yamaguchi T; Takahashi T
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):1060-4. PubMed ID: 2968778
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Application of immunotoxin in cancer therapy; its usefulness and problems in the future].
    Yamaguchi T; Takahashi T; Kitamura K; Noguchi A
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-1):1152-6. PubMed ID: 2471454
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased serum stability and prolonged biological half-life of neocarzinostatin covalently bound to monoclonal antibodies.
    Gottschalk U; Garnett MC; Ward RK; Maibücher A; Köhnlein W
    J Antibiot (Tokyo); 1991 Oct; 44(10):1148-54. PubMed ID: 1835456
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rhenium-186-mercaptoacetyltriglycine-labeled monoclonal antibody for radioimmunotherapy: in vitro assessment, in vivo kinetics and dosimetry in tumor-bearing nude mice.
    Kinuya S; Yokoyama K; Tega H; Hiramatsu T; Konishi S; Yamamoto W; Shuke N; Aburano T; Watanabe N; Takayama T; Michigishi T; Tonami N
    Jpn J Cancer Res; 1998 Aug; 89(8):870-8. PubMed ID: 9765625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Monoclonal antibody conjugated to gadolinium as a contrast agent for magnetic resonance imaging of human rectal carcinoma.
    Kuriu Y; Otsuji E; Kin S; Nakase Y; Fukuda K; Okamoto K; Hagiwara A; Yamagishi H
    J Surg Oncol; 2006 Aug; 94(2):144-8. PubMed ID: 16847923
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synthesis and biological evaluation of paclitaxel-C225 conjugate as a model for targeted drug delivery.
    Safavy A; Bonner JA; Waksal HW; Buchsbaum DJ; Gillespie GY; Khazaeli MB; Arani R; Chen DT; Carpenter M; Raisch KP
    Bioconjug Chem; 2003; 14(2):302-10. PubMed ID: 12643740
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Increased effect of neocarzinostatin bound to chimeric Fab fragments of monoclonal antibody A7 on the proliferation of human pancreatic carcinoma].
    Otsuji E; Kobayashi S; Nishida T; Yamamoto K; Matsumura H; Ichikawa D; Okamoto K; Shirasu M; Sakakura C; Kitamura K; Yamaguchi T
    Gan To Kagaku Ryoho; 1998 Sep; 25(11):1775-7. PubMed ID: 9757206
    [No Abstract]   [Full Text] [Related]  

  • 39. In vitro reactivity and in vivo biodistribution of the monoclonal antibody A7 using human gastric carcinoma cell lines.
    Yamaoka N; Yamaguchi T; Otsuji E; Kato M; Kotani T; Kitamura K; Takahashi T
    Br J Cancer; 1994 Sep; 70(3):405-8. PubMed ID: 8080722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor localization and in vivo antitumor activity of the immunoconjugate composed of anti-human colon cancer monoclonal antibody and mitomycin C-dextran conjugate.
    Noguchi A; Takahashi T; Yamaguchi T; Kitamura K; Takakura Y; Hashida M; Sezaki H
    Jpn J Cancer Res; 1991 Feb; 82(2):219-26. PubMed ID: 1706329
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.